Difference between revisions of "Part:BBa K3634004:Design"
(→Design Notes) |
|||
| Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
| − | Due to the two-phase nature of our project, the selected promoter and RBS used may be subject to change after wet lab application in 2021 to maximise shinorine production. Golden gate assembly methods will facilitate this optimisation if necessary. | + | Due to the two-phase nature of our project, the selected promoter and RBS used may be subject to change after wet lab application in 2021 to maximise shinorine production. Golden gate assembly methods will facilitate this optimisation if necessary. |
| − | + | ||
| − | + | ||
===Source=== | ===Source=== | ||
Revision as of 11:37, 22 July 2020
4-DG Pathway (E.coli Optimised)
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 7
Illegal NheI site found at 30 - 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Due to the two-phase nature of our project, the selected promoter and RBS used may be subject to change after wet lab application in 2021 to maximise shinorine production. Golden gate assembly methods will facilitate this optimisation if necessary.
Source
The initial genomic sequence came from Anabaena variabilis ATCC 29413 which can be obtained from parts BBa_K814000, BBa_K814002 and K8140001 (Minnesota iGEM, 2012) before being optimised using the IDT optimisation tool. The promoter and RBS were selected from each respective Anderson catalogue based on their relative strength. The terminator BBa_B0015 sequence can also be taken from the iGEM registry.